Sichuan Dazhou starts inhalation vaccination of new crown vaccine 6,210 doses of nebulized inhalation adenovirus vaccine have been received
Read Time:1 Minute, 14 Second
December 27, Sichuan Dazhou start inhalation new crown vaccination, the first batch of citizens to take the lead in using inhalation adenovirus vector new crown vaccine. It is understood that the inhalation type new crown vaccine is called recombinant new crown virus vaccine (type 5 adenovirus vector) for inhalation, which is a newly approved new crown vaccine in China. Compared with other muscle-injected vaccines, the inhalation type new crown vaccine uses the recombinant adenovirus vector process, without changing the composition of the vaccine, the vaccine is nebulized into an aerosol and inoculated by inhalation, which has the advantages of convenience, speed and painlessness.
At present, Dazhou has received 6,210 doses of nebulized inhaled adenovirus vaccine. People who wish to and are eligible for vaccination can make appointments at the vaccination clinics of community health service centers for consultation or telephone consultation.
It is understood that inhalation of the new crown vaccine, used for booster immunization, not for basic immunization. 18 years of age and above, all people can be nebulized with inhalation of adenovirus vaccine. For those aged 18 to 59 years, the inhalation vaccine will be administered at least 6 months after the completion of the basic immunization; for those aged 60 years or older, the booster vaccine will be administered 3 months after the completion of the basic immunization. For those who have been infected naturally before, a booster vaccination with nebulized inhalation can be given 6 months after complete recovery.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating